Sharp adds new clinical leadership
Sharp announced the appointment of Robert Feltz as Director, Analytical and Formulation Services and Michael MacNeir as Vice President, Global Business Development.
Robert Feltz moves to Sharp from Altasciences where he was Director of Analytical Services with responsibility for method validation, stability, and release testing. He also oversaw multiple drug candidates from pre-clinical to commercial launch.
Michael MacNeir joins Sharp from Marken where he was VP of Commercial Operations for the Americas. He brings over 14 years of clinical trial supply and operational experience, as well as a strong track record of success in commercial growth strategies.
“I am delighted to welcome Robert Feltz and Michael MacNeir to Sharp and I am confident they will make a significant contribution in shaping and growing our clinical business,” said Robert O’Beirn, Managing Director of Sharp Clinical. “Their respective industry expertise will put us in a stronger position to deliver and expand our client-led clinical solutions, to better serve our customers and their patients.”
